| 1 |
DPP-4 inhibitors: a patent review (2012 – 2014) |
|
| | Roberto Costante,Azzurra Stefanucci,Simone Carradori,Ettore Novellino,Adriano Mollica | | | Expert Opinion on Therapeutic Patents. 2014; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Dipeptidyl peptidase-4 inhibitors: Multitarget drugs, not only antidiabetes drugs |
|
| | Yunjuan Zhao,Lin Yang,Zhiguang Zhou | | | Journal of Diabetes. 2013; : n/a | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Erythrocyte mechanical fragility is increased in patients with type 2 diabetes |
|
| | Lippi, G., Mercadanti, M., Aloe, R., Targher, G. | | | European Journal of Internal Medicine. 2012; 23(2): 150-153 | | | [Pubmed] [Google Scholar] | | | 4 |
Erythrocyte mechanical fragility is increased in patients with type 2 diabetes |
|
| | Giuseppe Lippi,Mariella Mercadanti,Rosalia Aloe,Giovanni Targher | | | European Journal of Internal Medicine. 2012; 23(2): 150 | | | [Pubmed] [Google Scholar] [DOI] | |
|
